Showing results (841-850 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|September 5, 2014
Acquired resistance to gemcitabine and cross-resistance in human pancreatic cancer clonesHiroshi Yoneyama, Asako Takizawa-Hashimoto, Osamu Takeuchi, et al.Anti-Cancer Drugs|December 24, 2013
Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cellsErik Berglund, Sarojini Jayantha Kumari A Ubhayasekera, Fredrik Karlsson, et al.Anti-Cancer Drugs|July 8, 2014
Exogenous IL-1Ra attenuates intestinal mucositis induced by oxaliplatin and 5-fluorouracil through suppression of p53-dependent apoptosisXia Wang, Jin Gao, Lan Qian, et al.Anti-Cancer Drugs|December 25, 2013
Anticancer effect of bromelain with and without cisplatin or 5-FU on malignant peritoneal mesothelioma cellsKrishna Pillai, Anahid Ehteda, Javid Akhter, et al.Anti-Cancer Drugs|August 25, 2015
Para-toluenesulfonamide induces tongue squamous cell carcinoma cell death through disturbing lysosomal stabilityZhe Liu, Chenyuan Liang, Zhuoyuan Zhang, et al.Anti-Cancer Drugs|March 6, 2016
Benzothiazole derivatives bearing amide moiety: potential cytotoxic and apoptosis-inducing agents against cervical cancerMeenakshi Singh, Arusha Modi, Gopeshwar Narayan, et al.Anti-Cancer Drugs|December 4, 2015
Observation of hepatotoxicity during long-term gefitinib administration in patients with non-small-cell lung cancerJingjing Wang, Yanlin Wu, Mei Dong, et al.Anti-Cancer Drugs|July 21, 2017
Enhanced anticancer efficacy of histone deacetyl inhibitor, suberoylanilide hydroxamic acid, in combination with a phosphodiesterase inhibitor, pentoxifylline, in human cancer cell lines and in-vivo tumor xenograftsSaranya Nidhyanandan, Boreddy S Thippeswamy, Kottapalli B Chandrasekhar, et al.Anti-Cancer Drugs|July 12, 2016
Genitourinary tumours in the targeted therapies era: new advances in clinical practice and future perspectivesCarlo Messina, Giulia Buzzatti, Chiara Dellepiane, et al.Anti-Cancer Drugs|July 27, 2017
Solid lipid nanoparticles improve octyl gallate antimetastatic activity and ameliorate its renal and hepatic toxic effectsClarissa A S Cordova, Claudriana Locatelli, Evelyn Winter, et al.Pageof 464